Analyst Price Target is $125.63
▲ +12.82% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Abbott Laboratories in the last 3 months. The average price target is $125.63, with a high forecast of $140.00 and a low forecast of $110.00. The average price target represents a 12.82% upside from the last price of $111.35.
Current Consensus is
The current consensus among 15 polled investment analysts is to buy stock in Abbott Laboratories. This Buy consensus rating has held steady for over two years.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.